Skip to main content
Clinical Trials/NCT04154618
NCT04154618
Recruiting
N/A

Continuous Vital Sign Monitoring in Newborns

Northwell Health2 sites in 1 country1,000 target enrollmentFebruary 18, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Newborn Complication
Sponsor
Northwell Health
Enrollment
1000
Locations
2
Primary Endpoint
Assessment of feasibility by questionnaires to nurses and mothers using the using the Technology Acceptance Model (TAM).
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

This study evaluates the feasibility and usability of continuous wireless vital sign monitoring of well newborns during their birth hospitalization.

Detailed Description

This study is conducted for the purposes of understanding the feasibility and acceptability of routine wireless continuous monitoring on healthy newborns as a standard practice \& its effect on existing workflows and as a future tool for the early detection of undiagnosed problems. All infants will receive routine newborn nursing care . Once alarm limits have been determined, the monitoring data will be analyzed in real time and out of range vital signs will alert the nurse to perform standard assessment of the newborn. Nurse and parents will complete surveys regarding their experience with continuous vital sign monitoring.

Registry
clinicaltrials.gov
Start Date
February 18, 2020
End Date
December 31, 2025
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Barry Weinberger

Principal Investigator

Northwell Health

Eligibility Criteria

Inclusion Criteria

  • Healthy infants \<12 hours of age
  • Expected to be admitted to the Well Baby Nursery
  • 36 or more weeks gestation at birth
  • Mother at least 18 years of age

Exclusion Criteria

  • Infants requiring any non-routine medical care or observation
  • Neonatal Intensive Care Unit (NICU) or Special Care Nursery admission
  • Multiple birth

Outcomes

Primary Outcomes

Assessment of feasibility by questionnaires to nurses and mothers using the using the Technology Acceptance Model (TAM).

Time Frame: Up to 3 days

TAM questionnaires will be distributed to the nurse taking care of each subject at the time of discharge of the infant. The questionnaire will include informed consent by the nurse for participation in the research. A similar questionnaire will also be distributed to the mother just prior to discharge.

Secondary Outcomes

  • Accuracy assessed by comparison to conventional vital sign measurements within a 2-minute window(Up to 3 days)
  • Clinical Utility as measured by false alerts(Up to 3 days)

Study Sites (2)

Loading locations...

Similar Trials